# A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia

> **NCT06651515** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Seraxis**

## Conditions studied

- Diabetes Mellitus Type 1

## Interventions

- **BIOLOGICAL:** Allogeneic Pancreatic Endocrine Cell Clusters

## Key facts

- **NCT ID:** NCT06651515
- **Lead sponsor:** Seraxis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-04
- **Primary completion:** 2027-03
- **Final completion:** 2028-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study is being withdrawn for business reasons
- **Last updated:** 2025-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06651515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06651515, "A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06651515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*